The steady seven

Jim Collins's and Morten T. Hansen's "10X" companies outperformed their industries by a wide margin. Here's how they did it.

Amgen CEO Kevin Sharer
Not the most innovative biotech firm, but combination of creativity and discipline led it to outperform its industry from 1980 to 2002.

By Geoff Colvin, senior-editor-at-large - Last updated September 30 2011: 5:27 AM ET
Join the Conversation
How to manage through chaos

It's one thing to rise to greatness. It's another to do so in a time of upheaval, disruption, and economic turmoil (hello, 2011). How do some companies do it? Management guru Jim Collins shares the answers for the first time.

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.